Cargando…
How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity
Pyridoxamine, one of the natural forms of vitamin B(6), is known to be an effective inhibitor of the formation of advanced glycation end products (AGEs), which are closely related to various human diseases. Pyridoxamine forms stable complexes with metal ions that catalyze the oxidative reactions tak...
Autores principales: | Ramis, Rafael, Ortega-Castro, Joaquín, Caballero, Carmen, Casasnovas, Rodrigo, Cerrillo, Antonia, Vilanova, Bartolomé, Adrover, Miquel, Frau, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770850/ https://www.ncbi.nlm.nih.gov/pubmed/31480509 http://dx.doi.org/10.3390/antiox8090344 |
Ejemplares similares
-
Unravelling the effect of N(ε)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of α-synuclein
por: Mariño, Laura, et al.
Publicado: (2020) -
Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion
por: Uceda, Ana Belén, et al.
Publicado: (2022) -
Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products
por: Ahmad, Saheem, et al.
Publicado: (2013) -
Frataxins Emerge as New Players of the Intracellular Antioxidant Machinery
por: Uceda, Ana Belén, et al.
Publicado: (2021) -
Tyrosine Nitroxidation Does Not Affect the Ability of α-Synuclein to Bind Anionic Micelles, but It Diminishes Its Ability to Bind and Assemble Synaptic-like Vesicles
por: Uceda, Ana Belén, et al.
Publicado: (2023)